|
|
|
|
LEADER |
00899cam a2200241 7i4500 |
001 |
0000052668 |
005 |
20221102090000.0 |
008 |
190527 eng |
020 |
|
|
|a 0471432024
|
090 |
0 |
0 |
|a RC271.C5
|b M78 2004
|
245 |
0 |
0 |
|a Molecular cancer therapeutics :
|b strategies for drug discovery and development
|c edited by George C. Prendergast.
|
264 |
|
|
|a Hoboken, New Jersey:
|b Wiley-Liss,
|c 2004.
|
300 |
|
|
|a xiv, 351 pages:
|b illustrations;
|c 26 cm.
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a unmediated
|2 rdamedia
|
338 |
|
|
|a volume
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index
|
650 |
0 |
0 |
|a Cancer --
|x Immunotherapy
|
650 |
0 |
0 |
|a Cancer --
|x Chemotherapy
|
650 |
0 |
0 |
|a Antineoplastic agents --
|x Development
|
700 |
1 |
|
|a Prendergast, George C.
|
997 |
|
|
|a Health Sciences, Faculty
|
999 |
|
|
|a 0000065324
|b BOK
|c OPEN SHELF
|e 1st Floor, Shah Alam
|